ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 941,42
0,08%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pluristem Therapeutics Inc (PSTI)

  7. Pluristem Therapeutics Inc (PSTI) Actualités

PSTI

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PSTI
DateHeureSourceTitreSymboleSociété
09/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
01/06/202322h06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
09/05/202322h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
25/04/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202313h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202313h53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202314h59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
16/02/202314h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202312h27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
13/02/202322h39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
22/12/202214h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202223h17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
21/09/202222h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202213h00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
25/07/202207h00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
17/07/202214h20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
13/07/202212h00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
15/05/202214h25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
28/03/202209h00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
23/03/202212h30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
08/03/202213h12GlobeNewswire Inc.Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint VentureNASDAQ:PSTIPluristem Therapeutics Inc
02/03/202213h00GlobeNewswire Inc.Pluristem CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
24/02/202213h00GlobeNewswire Inc.Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food PlatformNASDAQ:PSTIPluristem Therapeutics Inc
10/01/202209h00GlobeNewswire Inc.Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food PlatformNASDAQ:PSTIPluristem Therapeutics Inc
05/01/202210h11TipRanksDawson James Maintains a Buy Rating on Pluristem (PSTI)NASDAQ:PSTIPluristem Therapeutics Inc
27/12/202113h00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19NASDAQ:PSTIPluristem Therapeutics Inc
15/11/202113h10GlobeNewswire Inc.Pluristem Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
10/11/202113h00GlobeNewswire Inc.Pluristem Receives Approval for Grant from the Israel Innovation Authority to Develop its Next-Generation CRISPR PLX PlatformNASDAQ:PSTIPluristem Therapeutics Inc
26/07/202122h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PSTIPluristem Therapeutics Inc
19/07/202113h00GlobeNewswire Inc.Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of DirectorsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI

Dernières Valeurs Consultées

EU
ORA
Orange
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
NASDAQ
NVDA
NVIDIA
EU
EN
Bouygues
EU
ML
Michelin
EU
HO
Thales
EU
PX1
CAC 40
EU
VIV
Vivendi
NYSE
MRK
Merck
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
RI
Pernod Ricard
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés